AN2 Therapeutics Inc. (ANTX) Business News Aug. 12, 2025, 11:01 UTC AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease Full text
There are no comments here yet...